Skip to main content

Table 2 Comparison of sensitiser enhancement ratios (SER) obtained using 160 kV and 6 MV X-ray sources

From: Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment

  160 kVp 6 MV
DU145
+ 1 µg Citrate-AuNP 0.9 1
+ RALA-AuNP 1.23 1.21
PC-3
+ 1 µg Citrate-AuNP 1.15 1.04
+ RALA-AuNP 1.54 1.31
PNT2-C2
+ 1 µg Citrate-AuNP 1.1 1
+ RALA-AuNP 0.96 1.014